Cardiac Rehab Post-atrial Fib Ablation

Atrial Fibrillation Clinical Trial

Official title:

Effect of Cardiac Rehabilitation Exercise on the Recurrence of Atrial Fibrillation in Post-ablation Patients: a Randomized Controlled Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05450731
• Other study ID #: 2022/05/04
• Status: Completed
• Phase: N/A
• Start date: May 14, 2022
• Est. completion date: January 13, 2024

Study information

• Verified date: February 2024
• Source: MultiCare Health System Research Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: January 13, 2024
• Est. primary completion date: June 14, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• ? Adult patients 18 years and older.

• Willing to participate in the study after randomization to either an intervention group (cardiac rehabilitation exercise) or a control group (usual care).

• Able to attend two pre and post study clinic visits at a local designated Pulse Heart Institute cardiac rehab program.

• If randomized to the cardiac rehab intervention group can attend exercise rehab visits for 3 x per week for 12 weeks (36 visits) at a designated Pulse cardiac rehab program.

• Has an active email address and phone number.

• Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation.

• Undergone ablation treatment and is at a minimum of 2 weeks post ablation status.

• Compliant with medication therapy including medications for heart rate control and anticoagulant(s).

Exclusion Criteria:

• ? Does not speak English.

• Does not have clearance to participate in the study by their attending cardiologist.

• Documented cardiovascular disease or pulmonary/respiratory disease that would qualify the patient for Cardiac, Pulmonary or Vascular Rehabilitation at a Pulse Heart Institute rehabilitation program.

• Dementia or cognitive impairment.

• Unable to participate in rehabilitation exercise due to physical limitations.

• Greater than one prior ablation procedure

• Long standing, chronic Atrial Fibrillation

• Patients who have undergone posterior wall isolation ablation.

Related Conditions & MeSH terms

• Atrial Fibrillation

Intervention

Other:
• 12-week supervised exercise based cardiac rehabilitation program
12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.

Locations

Country	Name	City	State
United States	Tacoma General Hospital	Tacoma	Washington

Sponsors (1)

Lead Sponsor	Collaborator
MultiCare Health System Research Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.	Examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation at 6- and 12-months post-ablation treatment.	12 months after the first intake appointment